-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Beijing, September 29, 2021/PRNewswire/ - On September 28, Biocytogen announced that it has reached an animal model sales cooperation with Envigo
.
Envigo is a multinational company that provides a wide range of research models and related services
The B-NDG mouse is a severely immunodeficient mouse constructed by knocking out the IL2rg gene on the NOD-scid background independently developed by Biocytogen
.
The mouse lacks mature T, B and functional NK cells, and exhibits a lack of cytokine signal transduction function.
Dr.
Adrian Hardy, President and CEO of Envigo, said: "Our cooperation with Biocytometer has further expanded the types of models that Envigo customers can choose.
The
B-NDG mouse model and the second-generation model built on this basis are important treatment methods.
The research and development of the company provides a powerful alternative to the existing immunodeficiency model
Dr.
Shen Yuelei, Chairman and CEO of Biocytometer, said: “Both companies are committed to providing excellent preclinical models for basic research and drug development
.
We believe that high-quality mouse models built on Biocytometer and Envigo World The cooperation of advanced breeding facilities and mouse health monitoring system can better meet the needs of related fields
ABOUT BIOSET
Biocytogen is an international biotechnology company that drives the research and development of new drugs with innovative technology.
It is committed to becoming the birthplace of global new drugs with the mission of focusing on technological innovation, continuous new drug production, and safeguarding human health
.
Based on the sound immune function, RenMab® and RenLite® mice, which can produce highly diversified and excellent affinity fully human antibodies, Biocytogen will integrate single-cell antibody discovery technology platform, gene editing model development platform, large-scale animal production platform and drug screening The platforms are organically integrated to form a unique new drug research and development system that covers the entire drug research and development process
Envigo (Envigo RMS LLC) provides a wide range of research models and related services to the pharmaceutical and biotechnology industries, government, academia, and other life science organizations
.
As the largest institution focusing on providing research models and related products and services, we are committed to helping researchers fully tap the potential of their important research and development projects, and work together with partners to complete the mission of building a healthier and safer world
